HOUSE_OVERSIGHT_024638.jpg

1.59 MB

Extraction Summary

0
People
3
Organizations
10
Locations
2
Events
0
Relationships
4
Quotes

Document Information

Type: Investment report / market analysis
File Size: 1.59 MB
Summary

This page is extracted from a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It provides a market overview, projecting the U.S. cannabis market to exceed $100 billion annually and the global market to reach $500 billion. The document discusses global legalization trends, medicinal benefits, and includes a map illustrating countries with various levels of cannabis legalization as of January 2018. The document bears the Bates stamp HOUSE_OVERSIGHT_024638, indicating it was part of a document production to the House Oversight Committee, though no specific mentions of Jeffrey Epstein appear on this single page.

Organizations (3)

Name Type Context
Ackrell Capital, LLC
FINRA
SIPC

Timeline (2 events)

January 2018
Date reference for the map of countries with legalized cannabis access
Global
Mid-2018
Expected enactment of recreational cannabis law in Canada
Canada

Key Quotes (4)

"the U.S. market will exceed $100 billion annually, with more than 50 million consumers."
Source
HOUSE_OVERSIGHT_024638.jpg
Quote #1
"Globally, we estimate that the legal cannabis market has the potential to reach $500 billion annually"
Source
HOUSE_OVERSIGHT_024638.jpg
Quote #2
"Cannabis legalization is gaining momentum around the world."
Source
HOUSE_OVERSIGHT_024638.jpg
Quote #3
"Contrary to U.S. federal law, 29 states, encompassing 62% of the U.S. population, permit the production and possession of cannabis"
Source
HOUSE_OVERSIGHT_024638.jpg
Quote #4

Full Extracted Text

Complete text extracted from the document (2,137 characters)

ACKRELL
CAPITAL
Cannabis Investment Report | December 2017
the U.S. market will exceed $100 billion annually, with more than 50 million consumers. Globally, we
estimate that the legal cannabis market has the potential to reach $500 billion annually, approaching
one billion consumers.
The Global Legal Cannabis Market
Cannabis legalization is gaining momentum around the world. This momentum is driven primarily by
the increasing recognition that cannabis may have a range of legitimate medicinal benefits and thera-
peutic applications. At least 20 countries now have medical laws that facilitate patient access to can-
nabis or cannabis concentrates for treating specified medical conditions. Notable countries with such
medical laws include Australia, Canada, Colombia and Germany; countries without such laws include
China, Japan, Russia and the United States. (Contrary to U.S. federal law, 29 states, encompassing
62% of the U.S. population, permit the production and possession of cannabis or concentrates for use
in treating a broad range of qualifying medical conditions.) While the merits of medical cannabis are
currently driving legalization, we believe that—like Uruguay and numerous U.S. states—other coun-
tries will ultimately enact legislation permitting the production, sale and use of recreational cannabis.
(Canada is widely expected to do so in mid-2018.)
The following world map illustrates select countries that (i) have enacted medical laws that facilitate
patient access to cannabis or concentrates for treating specified medical conditions, (ii) have enacted
recreational laws that permit the commercial production and sale of cannabis to adults for recreational
and other uses, or (iii) include a state or province that has a cannabis law or policy in conflict with
federal law.
Select Countries with Legalized Cannabis Access (January 2018)
[Map Graphic]
Recreational Law*
Medical Law
State/Province Conflict
with Federal Law
*Canada currently has a medical law. Assumes Canada enacts a proposed recreational law in mid-2018.
2 © 2017 Ackrell Capital, LLC | Member FINRA / SIPC
HOUSE_OVERSIGHT_024638

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document